Clinical Trials for Metastatic Triple-Negative Breast Carcinoma

Find clinical trials for metastatic triple-negative breast carcinoma. Discover research opportunities and treatment options in your area.

19 Active Trials Found

Showing 19 trials on this page

Page 1 of 1

Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer

NCT ID: NCT06434064

This clinical trial is exploring a new treatment approach for patients with metastatic or inoperable locally advanced triple-negative breast cancer, which is a type of breast cancer that does not r...

Recruiting

Phase: PHASE2 Type: interventional Locations: Buffalo, New York, United States

Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer

NCT ID: NCT06324240

This clinical trial is studying a new treatment approach for triple-negative breast cancer, a type of breast cancer that does not have specific receptors known to fuel most breast cancer growth. Th...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Atlanta, Georgia, United States, Atlanta, Georgia, United States +2 more

Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer

NCT ID: NCT05422794

This clinical trial is investigating a new treatment approach for patients with advanced triple-negative breast cancer, which is a type of breast cancer that does not respond to certain hormone the...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States +3 more

Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer

NCT ID: NCT06774027

This clinical trial is studying the use of a new type of treatment called antibody-drug conjugates (ADCs) for patients with advanced breast cancer that is either HER2-negative or hormone receptor-p...

Not yet recruiting

Type: observational Locations: San Francisco, California, United States

A Study of Pembrolizumab and Cryoablation in People With Breast Cancer

NCT ID: NCT06246968

This clinical trial is looking at the use of a medication called pembrolizumab, combined with a treatment called cryoablation, for people with advanced types of breast cancer, especially those with...

Recruiting

Phase: PHASE1 Type: interventional Locations: Middletown, New Jersey, United States, Montvale, New Jersey, United States +5 more

Ivermectin and Balstilimab for the Treatment of Metastatic Triple Negative Breast Cancer

NCT ID: NCT05318469

This clinical trial is studying a new treatment for patients with metastatic triple-negative breast cancer, which is a type of breast cancer that has spread to other parts of the body. The research...

Recruiting

Phase: PHASE1 Type: interventional Locations: Los Angeles, California, United States, Duarte, California, United States

Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer

NCT ID: NCT05741164

This clinical trial is studying the combination of two medications, propranolol and pembrolizumab, to see if they can help treat women with a type of breast cancer called triple-negative breast can...

Recruiting

Phase: PHASE2 Type: interventional Locations: Buffalo, New York, United States

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

NCT ID: NCT03606967

This clinical trial is investigating a new treatment approach for patients with metastatic triple-negative breast cancer, which is a type of breast cancer that has spread to other parts of the body...

Recruiting

Phase: PHASE2 Type: interventional Locations: New Haven, Connecticut, United States, Lebanon, New Hampshire, United States +30 more

Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy

NCT ID: NCT05770531

This clinical trial is studying a new way to help doctors decide when to change chemotherapy for patients with metastatic triple-negative breast cancer (TNBC) that has spread to other parts of the ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Nashville, Tennessee, United States

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

NCT ID: NCT06176261

The DATO-BASE clinical trial is studying a new drug called datopotamab deruxtecan to see how safe and effective it is for treating breast cancer that has spread to the brain. This trial is specific...

Recruiting

Phase: PHASE2 Type: interventional Locations: Durham, North Carolina, United States, Boston, Massachusetts, United States +2 more

Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

NCT ID: NCT04348747

This clinical trial is exploring a new treatment approach for women with advanced breast cancer that has spread to the brain. Specifically, it is looking at how well a special type of vaccine, call...

Recruiting

Phase: PHASE2 Type: interventional Locations: Buffalo, New York, United States, Tampa, Florida, United States +1 more

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

NCT ID: NCT06492759

This clinical trial is studying a new treatment approach for patients with a specific type of breast cancer called PD-L1 positive metastatic triple-negative breast cancer. The treatment combines hi...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Atlanta, Georgia, United States

Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in Metastatic Triple Negative Breast Cancer

NCT ID: NCT05742269

This clinical trial is exploring a new way to help doctors choose the best treatment for patients with metastatic triple-negative breast cancer (mTNBC). The study is testing a special type of imagi...

Recruiting

Type: observational Locations: Stockholm, , Sweden

NBTXR3 Activated by Radiotherapy for Patients with Advanced Cancers Treated with an Anti-PD-1 Therapy

NCT ID: NCT03589339

The clinical trial titled "NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy" is exploring a new treatment approach for patients with advanced ca...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Tampa, Florida, United States +14 more

Neratinib in Combination With Ruxolitinib in Patients With mTNBC

NCT ID: NCT06008275

This clinical trial is studying the combination of two medications, neratinib and ruxolitinib, to see how safe and effective they are for women with metastatic triple-negative breast cancer (mTNBC)...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Dallas, Texas, United States

Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Treatment

NCT ID: NCT06505018

This clinical trial is studying whether a digital health tool called "CUREETY TECHCARE" can help patients with metastatic triple-negative breast cancer feel better and stay healthier while they sta...

Recruiting

Phase: NA Type: interventional Locations: Lyon, , France, Marseille, , France +49 more

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

NCT ID: NCT05269381

This clinical trial is investigating a new type of personalized vaccine designed to help the immune system recognize and attack advanced solid tumors, which are cancers that have spread beyond thei...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jacksonville, Florida, United States

Treatment of Advanced or Metastatic Triple-negative Breast Cancer With Adoptive Therapy of PD1+ TILS

NCT ID: NCT05451784

This clinical trial is investigating a new treatment for advanced or metastatic triple-negative breast cancer (TNBC) using a method called PD1+ TILs infusion. TILs, or tumor-infiltrating lymphocyte...

Recruiting

Phase: PHASE1 Type: interventional Locations: Barcelona, , Spain, Madrid, , Spain +2 more

The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC

NCT ID: NCT04664829

This clinical trial is studying a drug called Bexarotene to see if it can help make chemotherapy more effective for women with metastatic triple-negative breast cancer (TNBC). TNBC is a type of bre...

Recruiting

Phase: PHASE1 Type: interventional Locations: Singapore, , Singapore

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions